0.08 | 1.43%
| Price and Volume | |
|---|---|
| Recent Price | 5.49 |
| 52 Week High | 9.26 |
| 52 Week Low | 4.20 |
| Avg. Daily Vol. (Mil) | 0.39 |
| Beta (3 year) | 1.36 |
| Share Related Items | |
| Mkt Cap (Mil) | 305.95 |
| Shares Out (Mil) | 55.73 |
| Float (Mil) | 55.27 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 2.90 |
| Current Ratio | 3.20 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | 0.00 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 4.59 |
| Price/Book | 3.09 |
| Price/Cash Flow | -8.40 |
| Per Share Data | |
| Earnings | -0.67 |
| Sales | 1.20 |
| Book Value | 1.78 |
| Cash Flow | -0.65 |
| Business Summary | |
|---|---|
| DepoMed, Inc company, is focused on the development and commercialization of differentiated products that address large and growing markets and are based on proprietary oral drug delivery technologies. | |
| General Information | |
| 1360 O'Brien Drive
Menlo Park, CA 94025 |
|
| www.depomedinc.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 110 | |
| CEO: James A. Schoeneck | |
| Short Interest | |
| Current Month (Mil) | 3.69 |
| Previous Month (Mil) | 3.84 |
| Short Interest Ratio (Days) | 8.60 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -24.30 |
| Return on Investments | -37.00 |
| Profitability | |
| Gross Margin | 94.10 |
| EBIT Margin | -54.60 |
| Profit Margin | -55.30 |
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,606.76 | 1,334.56 | 2,878.49 | 17.33 |
Oil *
107.55
|
|
UP
151.93 |
UP
16.74 |
UP
40.96 |
DOWN
0.12 |
10 Yr
1.73%
SPDR Gold
153.42
|
|
+1.22%
|
+1.27%
|
+1.44%
|
-0.69%
|
Data delayed 20 minutes |
Connect with TheStreet